Tetrahydro-4-oxo-3-furancarboxylic Acid Methyl Ester, is used for the preparation of fused-pyrimidine derivatives as a series of novel GPR119 agonists.
參考文獻
Negoro, K., et al.: Bioorg. Med. chem., 20, 6442 (2012); Goto, T., et al.: Bioorg. Med. Chem. Lett., 23, 3325 (2013);
滬ICP備17019645號
400-821-0725
